Bright Minds Biosciences Inc. · CSE:DRUG
Janus Henderson Group PLC reported a 16.30% stake in Bright Minds Biosciences Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Janus Henderson Group PLC reported a 16.30% stake in Bright Minds Biosciences Inc., 1,145,660 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 16.30%
- Shares
- 1,145,660
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 16.30% | 1,145,660 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 14.00% | 984,485 |
Source
Related
- Bright Minds Biosciences Inc.
- Janus Henderson Group PLC
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Feb 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Apr 7, 2025
- Schedule 13G · Janus Henderson Group PLC · Feb 7, 2025
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · May 12, 2026